Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing 
SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure 
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock 
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal 
Oil Prices Slip as U.S.–Iran Talks Ease Supply Disruption Fears 
FDA Fast-Track Drug Reviews Delayed Over Safety and Efficacy Concerns 
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
The Korea Photonics Technology Institute has developed a free-space augmented reality (AR) system that allows examination of breast cancer tissue’s location and shape through the naked eye.
The system, developed in collaboration with the institution, local AR developer Apros Corp., and the National Cancer Center, uses a small light projection device to broadcast a video of breast cancer captured by a camera onto the afflicted region for surgeons.
The near-infrared fluorescence probe video system that is typically used for breast cancer surgery does not allow surgeons to see the wavelength of the light generated by the fluorescent contrast agent with their naked eyes, necessitating the use of a separate monitor with a dedicated camera for the surgery.
The innovative method reflects real-time changes in the position of breast cancer cells caused by human tissue flexibility, and shows the video immediately on the affected area to aid the surgeon's attention, reducing the time spent on the surgery.
The new technology has passed performance tests utilizing National Cancer Center-created breast cancer models and animal testing, with medical certification and clinical trials scheduled for the near future.
